Second interim analysis of a phase 3 study evaluating idelalisib and rituximab for relapsed CLL Meeting Abstract


Authors: Coutre, S. E.; Furman, R. R.; Sharman, J. P.; Cheson, B. D.; Pagel, J. M.; Hillmen, P.; Barrientos, J. C.; Zelenetz, A. D.; Kipps, T. J.; Flinn, I.; Ghia, P.; Eradat, H. A.; Ervin, T. J.; Lamanna, N.; Coiffier, B.; Pettitt, A.; Kim, Y.; Jahn, T. M.; O'Brien, S. M.; Hallek, M. J.
Abstract Title: Second interim analysis of a phase 3 study evaluating idelalisib and rituximab for relapsed CLL
Meeting Title: 50th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 32
Issue: 15 Suppl.
Meeting Dates: 2014 May 30-Jun 3
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2014-05-20
Language: English
ACCESSION: WOS:000358613203830
PROVIDER: wos
Notes: Meeting Abstract: 7012 -- Source: Wos
MSK Authors
  1. Nicole Lamanna
    57 Lamanna
  2. Andrew D Zelenetz
    547 Zelenetz